Novartis Avidity Biosciences in talks

Signage for Novartis AG at a building in the company’s headquarters campus in Basel, Switzerland, on Monday, Jan. 8, 2023.  Bloomberg | Bloomberg | Getty Images Swiss pharmaceutical giant Novartis is nearing a deal to buy biotechnology company Avidity Biosciences for more than $70 a share, Bloomberg News reported, citing a person familiar with the…

Read Full News

Family offices fear dollar depreciation, lower returns in wake of tariffs

Compassionate Eye Foundation/david Oxberry | Digitalvision | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Family offices have been investing with more caution since President Donald Trump’s tariff announcement…

Read Full News